SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John McCarthy who wrote (404)5/11/1998 4:48:00 PM
From: Robert DeHaven  Read Replies (2) of 1510
 
IMHO...John: Buying is driving this stock.

For what reason are people buying because 1) The rotation of investment has come to biotechs 2)This company is coming to the end of a long expensive road involving trials of Remune 3) The RA business is promising 4) They also have promising applications involving gene therapy....

Fast track approval of Remune has been speculated.
Corporate partnerships have been rumoured and hinted at by the company and PR.
Private Placement at above market prices
Institutional interest is now apparant.
Prudential started coverage with a buy last week...and is also making a market in the stock....

Very strong bullish driving forces...

good luck,

bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext